About Gilteritinib 40 mg Tablet
Gilteritinib 40 mg tablet is a targeted therapy used in treating acute myeloid leukemia (AML), particularly in patients with a FLT3 mutation. This mutation drives the rapid growth of abnormal white blood cells, and gilteritinib works by blocking this signal.
It is commonly introduced when AML does not respond to initial treatment or returns after remission, making it a key option in advanced leukemia management.
When is Gilteritinib Prescribed?
Doctors may recommend Gilteritinib tablets in the following situations:
- AML with confirmed FLT3 mutation
- Relapsed or treatment-resistant leukemia
- Patients requiring targeted therapy instead of traditional chemotherapy
- Cases where disease progression needs to be controlled
Genetic testing is essential before starting treatment to ensure the medicine is appropriate.
Access & Availability in the Philippines
Availability of targeted AML therapies like gilteritinib can differ across the Philippines, especially outside major hospitals.
Through LetsMeds, patients in cities such as Manila, Cebu, and Davao can explore reliable access to Gilteritinib 40 mg tablets via international supply channels.
This helps patients manage treatment continuity when local availability is limited or inconsistent.
Safety Profile & Side Effects
Like most targeted cancer medicines, Gilteritinib 40 mg may cause side effects that require monitoring.
Frequently Reported:
- Fatigue or weakness
- Fever
- Diarrhea
- Muscle or joint discomfort
- Nausea
Important but Less Common:
- Differentiation syndrome (requires urgent care)
- Liver enzyme changes
- Heart rhythm issues
- Blood pressure fluctuations
Regular follow-ups and lab tests are important during treatment.
Common Questions Patients Ask
How to take Gilteritinib for AML?
It is usually taken once daily at the same time each day, as directed by a healthcare provider.
Is Gilteritinib chemotherapy?
No, it is a targeted therapy designed to act on specific genetic mutations in AML.
What makes Gilteritinib different from other AML treatments?
It specifically targets FLT3 mutations, which are linked to aggressive disease progression.
Can Gilteritinib be used long-term?
Yes, treatment may continue as long as it remains effective and tolerable.
Where can patients access Gilteritinib tablets?
Patients can explore global supply options through LetsMeds with delivery support in multiple regions.
Disclaimer
The information provided here is for educational purposes only and should not be considered medical advice. Gilteritinib 40 mg tablets should be used only under the supervision of a qualified healthcare professional. Always consult your doctor before starting or changing any medication. LetsMeds does not promote self-medication and encourages safe and responsible use of all pharmaceutical products.
